Treace Medical Concepts (TMCI)
(Delayed Data from NSDQ)
$6.18 USD
+0.20 (3.34%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $6.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.27 | 0.00% |
Earnings Summary
For their last quarter, Treace Medical Concepts (TMCI) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.29 per share. This reflects a negative earnings surprise of 17.24%. Look out for TMCI's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.27 per share, reflecting a year-over-year increase of 3.57%.
Earnings History
Price & Consensus
Zacks News for TMCI
RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2
TMCI: What are Zacks experts saying now?
Zacks Private Portfolio Services